Boey in Canada: Approved, Not Yet Available

What Is Boey?

Boey® is a botulinum toxin injectable from AbbVie — the same company behind Botox®. What makes it unusual is the molecule: its active ingredient is trenibotulinumtoxinE, a type E botulinum toxin. Every other neuromodulator used in Canadian aesthetics today — Botox®, Dysport®, Xeomin®, Letybo® — is a type A toxin. Boey is the first type E product to reach Canadian authorization.

Can You Get Boey in Canada Right Now?

The honest answer: not yet. Boey was authorized by Health Canada on 22 June 2026 (DIN 02569086, AbbVie Corporation), but Health Canada’s Drug Product Database records no market date for it. Authorization and availability are two different milestones — a product can be approved months before it is actually distributed to clinics.

So you will not find Boey on our treatment menu, and you should be cautious of any Canadian clinic advertising Boey injections today. We will add it when our supplier can actually deliver it and when the Canadian product monograph is in hand — not before.

The Science: Why a Type E Toxin Behaves Differently

All botulinum toxins stop a nerve from telling a muscle to contract, but they do not do it the same way or for the same length of time. Type E is studied for a faster onset and a markedly shorter duration than the type A products in routine use. That is a genuinely different profile rather than a marketing distinction.

A short-acting neuromodulator is interesting for a specific kind of patient: someone trying injectables for the first time who wants a reversible-feeling trial, or someone who wants a defined effect around a single event. It is less interesting if your goal is the longest possible result per appointment — which is what most people actually want, and what type A does better.

One practical point worth stating early: units do not convert between products. A Boey vial is 1400 units, a Botox Cosmetic vial is 100 units, a Letybo vial is 50 units. Those numbers describe different things and cannot be compared across brands — including on price.

What We Offer in Markham & Toronto Today

• Botox® — onabotulinumtoxinA, the most studied type A product and the dosing reference for the category.
• Dysport® — a wider field of diffusion, which can suit larger muscle areas such as the forehead or trapezius.
• Xeomin® — formulated without complexing proteins.
• Letybo® — letibotulinumtoxinA from Hugel, used at our clinic mainly for frown lines.

How these differ, and how a product is chosen for a given muscle, is set out on our botulinum toxin treatment overview. For a side-by-side of the type A brands, see Botox vs Dysport vs Xeomin.

Talk to a Physician, Not a Launch Date

At ID Cosmetic Clinic (30 Gibson Dr, Markham), Dr. Dan Xu, MD, CCFP injects every treatment personally and selects the product from your anatomy, your previous response and your goal — not from whichever brand is newest. If Boey turns out to suit a specific goal of yours once it is available here, we will say so. Serving Toronto, Markham and the GTA. Call 905-477-2225 for a free 30-minute consultation.

Regulatory details in this article are taken from the Health Canada Drug Product Database (DIN 02569086) and were last verified on 15 September 2026. Availability can change — call the clinic to confirm current options.